SCHEMBL2595556

SCHEMBL2595556

CC1(c2ccc3nc[nH]c3c2)CCCN1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.47
HSD11B1 P28845 4/20 0.43
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
RAF1 P04049 1/20 0.39
BRAF P15056 1/20 0.39
CTNNB1 P35222 1/20 0.38
WNT3A P56704 1/20 0.38
CYP3A4 P08684 1/20 0.38
NAMPT P43490 1/20 0.38
XDH P47989 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4664222 0.96 EPHX2 (0.44) EPHX2HSD11B1ALDH1A1HPGDKDM4E
SCHEMBL2595560 0.91 EPHX2 (0.41) EPHX2HSD11B1ALDH1A1HPGD
SCHEMBL4664227 0.87 EPHX2 (0.38) EPHX2HSD11B1ALDH1A1HPGDKDM4E
SCHEMBL1078194 0.80 RAF1 (0.40) EPHX2HSD11B1ALDH1A1HPGDKDM4E
SCHEMBL7449809 0.72 HSD11B1 (0.51) EPHX2HSD11B1ALDH1A1HPGDKDM4E
SCHEMBL908982 0.72 HSD11B1 (0.44) EPHX2HSD11B1ALDH1A1
SCHEMBL19459187 0.71 HSD11B1 (0.45) EPHX2HSD11B1ALDH1A1EPHX1
SCHEMBL19462895 0.71 HSD11B1 (0.45) EPHX2HSD11B1ALDH1A1EPHX1
SCHEMBL26635227 0.71 HSD11B1 (0.34) EPHX2HSD11B1
SCHEMBL1078190 0.71 EPHX2 (0.34) EPHX2HSD11B1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563123-A1 NOVEL BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2013-03-06 EP disclosed
WO-2011137054-A1 NOVEL BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2011-11-03 WO disclosed